0000919574-23-004721.txt : 20230814 0000919574-23-004721.hdr.sgml : 20230814 20230814113539 ACCESSION NUMBER: 0000919574-23-004721 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAXTON CORP CENTRAL INDEX KEY: 0001388551 IRS NUMBER: 222437619 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15293 FILM NUMBER: 231167559 BUSINESS ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-419-1800 MAIL ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false true false 0001388551 XXXXXXXX 06-30-2023 06-30-2023 false CAXTON CORP
731 Alexander Road Building 2, Suite 500 Princeton NJ 08540
13F HOLDINGS REPORT 028-15293 N
Heath Weisberg Chief Compliance Officer 212-205-6805 /s/ Heath Weisberg Princeton NJ 08-14-2023 0 7 34653386 true
INFORMATION TABLE 2 infotable.xml ALLAKOS INC COM 01671P100 77318 17733 SH SOLE 17733 0 0 COMPASS THERAPEUTICS INC COM 20454B104 138220 43466 SH SOLE 43466 0 0 ELEVATION ONCOLOGY INC COM 28623U101 33022 21725 SH SOLE 21725 0 0 MOLECULAR TEMPLATES INC COM 608550109 985436 2052991 SH SOLE 2052991 0 0 REZOLUTE INC COM NEW 76200L309 2611555 1318967 SH SOLE 1318967 0 0 SAVARA INC COM 805111101 16026005 4980804 SH SOLE 4980804 0 0 XERIS BIOPHARMA HOLDINGS INC COM 98422E103 14781830 5641920 SH SOLE 5641920 0 0